Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.2322
-0.0002 (-0.09%)
At close: Sep 12, 2025, 4:00 PM EDT
0.2311
-0.0011 (-0.47%)
After-hours: Sep 12, 2025, 7:48 PM EDT
Intensity Therapeutics Stock Forecast
INTS's stock price has decreased by -94.5% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts that cover Intensity Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $4.50, which forecasts a 1,837.98% increase in the stock price over the next year. The lowest target is $1.50 and the highest is $8.50.
Price Target: $4.50 (+1,837.98%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Intensity Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Maintains $4 → $1.5 | Buy | Maintains | $4 → $1.5 | +545.99% | Aug 20, 2025 |
| Brookline Capital | Brookline Capital | Hold → Strong Buy Upgrades $3 | Hold → Strong Buy | Upgrades | $3 | +1,191.99% | Aug 12, 2025 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $8.5 | Strong Buy | Initiates | $8.5 | +3,560.64% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +2,053.32% | Nov 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +2,053.32% | Oct 31, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.50
from -1.17
EPS Next Year
-0.33
from -0.50
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.37 | -0.24 | |||
| Avg | -0.50 | -0.33 | |||
| Low | -0.69 | -0.49 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.